掃碼下載
BTC $76,158.08 +2.07%
ETH $2,366.92 +1.22%
BNB $633.99 +2.00%
XRP $1.45 +2.87%
SOL $88.57 +3.87%
TRX $0.3242 -0.82%
DOGE $0.0998 +3.28%
ADA $0.2595 +3.87%
BCH $450.51 +2.45%
LINK $9.58 +2.75%
HYPE $43.87 -2.47%
AAVE $116.79 +9.39%
SUI $1.00 +2.65%
XLM $0.1694 +4.81%
ZEC $337.66 -1.50%
BTC $76,158.08 +2.07%
ETH $2,366.92 +1.22%
BNB $633.99 +2.00%
XRP $1.45 +2.87%
SOL $88.57 +3.87%
TRX $0.3242 -0.82%
DOGE $0.0998 +3.28%
ADA $0.2595 +3.87%
BCH $450.51 +2.45%
LINK $9.58 +2.75%
HYPE $43.87 -2.47%
AAVE $116.79 +9.39%
SUI $1.00 +2.65%
XLM $0.1694 +4.81%
ZEC $337.66 -1.50%

生物科技公司 BioNexus Gene Lab 董事會批准將部分資金配置於以太坊生態系統

2025-03-06 10:21:06
收藏

ChainCatcher 消息,据 Globe Newswire 報導,生物科技公司 BioNexus Gene Lab Corp 董事會已批准以太坊財庫戰略並發布相關戰略白皮書,將部分資金配置於以太坊生態系統。

該公司表示,這一戰略旨在優化公司財務管理,同時探索區塊鏈技術在生物科技領域的應用潛力。戰略白皮書詳細闡述了公司如何利用以太坊網絡的智能合約功能和去中心化特性,為其業務發展創造新機遇。

app_icon
ChainCatcher 與創新者共建Web3世界